Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • BBY vs GSK✓SelectedUSD · GSKBBY vs GSK performance historyLatest closeAs of-4.79%11/17
Stock and ETF performance explorer

BBY vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+215.9%
GSK return
+103.9%
Excess return
+112.0%
Maximum drawdown
-52.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-4.8%-2.3%-2.5%-4.0%
7D-5.5%-3.0%-2.5%-4.5%
30D+6.2%+0.4%+5.9%+6.2%
3M+16.4%-1.2%+17.6%+16.9%
6M+79.0%+0.9%+78.1%+78.0%
YTD+52.8%+4.0%+48.8%+49.7%
1Y+38.8%+7.3%+31.5%+34.6%
3Y+66.9%+57.1%+9.8%+37.5%
5Y-6.5%+43.0%-49.4%-21.9%
All+215.9%+103.9%+112.0%+124.7%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling